摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

橙皮素二氢查耳酮 | 35400-60-3

中文名称
橙皮素二氢查耳酮
中文别名
——
英文名称
3-(3-hydroxy-4-methoxy-phenyl)-1-(2,4,6-trihydroxyphenyl)propan-1 -one
英文别名
3-(3-hydroxy-4-methoxyphenyl)-1-(2,4,6-trihydroxyphenyl)-1-propanone;hesperetin dihydrochalcone;3-(3-hydroxy-4-methoxy-phenyl)-1-(2,4,6-trihydroxy-phenyl)-propan-1-one;3-(3-Hydroxy-4-methoxy-phenyl)-1-(2,4,6-trihydroxy-phenyl)-propan-1-on;3-Hydroxy-4-O-methyl-phloretin;Hesperetin-dihydrochalcon;3-(3-hydroxy-4-methoxyphenyl)-1-(2,4,6-trihydroxyphenyl)propan-1-one
橙皮素二氢查耳酮化学式
CAS
35400-60-3
化学式
C16H16O6
mdl
MFCD00016768
分子量
304.299
InChiKey
RWKSTZADJBEXSQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    553.1±38.0 °C(Predicted)
  • 密度:
    1.409±0.06 g/cm3(Predicted)
  • LogP:
    3.210 (est)
  • 物理描述:
    Slightly grey solid; Bland aroma
  • 溶解度:
    Practically insoluble to insoluble

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    22
  • 可旋转键数:
    5
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.187
  • 拓扑面积:
    107
  • 氢给体数:
    4
  • 氢受体数:
    6

安全信息

  • 危险性防范说明:
    P501,P270,P264,P280,P302+P352,P337+P313,P305+P351+P338,P362+P364,P332+P313,P301+P312+P330
  • 危险性描述:
    H302,H315,H319

SDS

SDS:8d8980c7fd208361f8648c47a855a749
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    橙皮素二氢查耳酮 生成 5,7-dihydroxy-3-[(3-hydroxy-4-methoxyphenyl)methyl]chromen-4-one
    参考文献:
    名称:
    SATHYANARAYANA, S.;KRISHNAMURTY, H. G., INDIAN J. CHEM. B, 27,(1988) N0, C. 899-901
    摘要:
    DOI:
  • 作为产物:
    描述:
    橙皮素 在 5%-palladium/activated carbon 、 甲酸铵 作用下, 以 乙醇 为溶剂, 以87.6%的产率得到橙皮素二氢查耳酮
    参考文献:
    名称:
    [EN] METHOD FOR PRODUCING HESPERETIN DIHYDROCHALCONE
    [FR] PROCÉDÉ DE PRODUCTION D'HESPÉRÉTINE DIHYDROCHALCONE
    摘要:
    The present invention relates to a method for producing hesperetin dihydrochalcone from hesperetin as starting material. Furthermore, the present invention relates to a method for imparting or modifying a sweet taste impression.
    公开号:
    WO2023138777A1
点击查看最新优质反应信息

文献信息

  • USE OF 3-(3-HYDROXY-4-METHOXY-PHENYL)-1-(2,4,6-TRIHYDROXY-PHENYL) PROPAN-1-ONE
    申请人:SYMRISE AG
    公开号:US20190343777A1
    公开(公告)日:2019-11-14
    The present invention concerns the use of 3-(3-Hydroxy-4-methoxy-phenyl)-1-(2,4,6-trihydroxyphenyl)propan-1-one for masking, reducing or suppressing an unpleasant taste impression, preferably bitter, sour and/or astringent taste impression of unpleasant-tasting substances or mixture of substances, preferably bitter-, sour-, and/or astringent-tasting substances or mixtures of substances, and in particular the bitter taste impression of bitter-tasting substances, and/or modulating the taste impressions selected from the group consisting of cooling, umami, fruity and spicy notes of cooling-, umami-, fruity- or spicy-tasting substances or mixture of substances, and simultaneously intensifying the sweet-taste impression of sweet-tasting substances or mixtures of substances or both sweet- and bitter-tasting tasting substances or mixture of substances.
    本发明涉及使用3-(3-羟基-4-甲氧基苯基)-1-(2,4,6-三羟基苯基)丙酮来掩盖、减少或抑制令人不愉快的味觉印象,优选是苦、酸和/或涩的不愉快味觉印象的不愉快味道物质或物质混合物,优选是苦味、酸味和/或涩味物质或物质混合物,特别是苦味物质的苦味印象,和/或调节选自冷却、鲜味、果味和辛辣味的味觉印象的味道物质或物质混合物,同时增强甜味物质或物质混合物或甜味和苦味物质或物质混合物的甜味印象。
  • Identification of Interleukin-8-Reducing Lead Compounds Based on SAR Studies on Dihydrochalcone-Related Compounds in Human Gingival Fibroblasts (HGF-1 cells) In Vitro
    作者:Katharina Schueller、Joachim Hans、Stefanie Pfeiffer、Jessica Walker、Jakob P. Ley、Veronika Somoza
    DOI:10.3390/molecules25061382
    日期:——

    Background: In order to identify potential activities against periodontal diseases, eighteen dihydrochalcones and structurally related compounds were tested in an established biological in vitro cell model of periodontal inflammation using human gingival fibroblasts (HGF-1 cells). Methods: Subsequently to co-incubation of HGF-1 cells with a bacterial endotoxin (Porphyromonas gingivalis lipopolysaccharide, pgLPS) and each individual dihydrochalcone in a concentration range of 1 µM to 100 µM, gene expression of interleukin-8 (IL-8) was determined by qPCR and cellular interleukin-8 (IL-8) release by ELISA. Results: Structure–activity analysis based on the dihydrochalcone backbone and various substitution patterns at its aromatic ring revealed moieties 2′,4,4′,6′-tetrahydroxy 3-methoxydihydrochalcone (7) to be the most effective anti-inflammatory compound, reducing the pgLPS-induced IL-8 release concentration between 1 µM and 100 µM up to 94%. In general, a 2,4,6-trihydroxy substitution at the A-ring and concomitant vanilloyl (4-hydroxy-3-methoxy) pattern at the B-ring revealed to be preferable for IL-8 release inhibition. Furthermore, the introduction of an electronegative atom in the A,B-linker chain led to an increased anti-inflammatory activity, shown by the potency of 4-hydroxybenzoic acid N-vanillylamide (13). Conclusions: Our data may be feasible to be used for further lead structure designs for the development of potent anti-inflammatory additives in oral care products.

    背景:为了识别针对牙周疾病的潜在活性,对十八种二氢黄酮类化合物及结构相关化合物在已建立的人牙龈成纤维细胞(HGF-1细胞)牙周炎生物体外细胞模型中进行了测试。方法:在HGF-1细胞与一种细菌内毒素(牙龈脓毒素脂多糖,pgLPS)和每种单独的二氢黄酮类化合物在1 µM至100 µM浓度范围内共同孵育后,通过qPCR测定白细胞介素-8(IL-8)的基因表达,并通过ELISA测定细胞白细胞介素-8(IL-8)的释放。结果:基于二氢黄酮骨架和其芳香环上的各种取代模式的结构-活性分析显示,2′,4,4′,6′-四羟基-3-甲氧基二氢黄酮(7)是最有效的抗炎化合物,将pgLPS诱导的IL-8释放浓度在1 µM至100 µM之间降低了94%。一般来说,A环上的2,4,6-三羟基取代和B环上的香草酰(4-羟基-3-甲氧基)模式同时出现,对于IL-8释放抑制是首选。此外,在A、B连接链中引入一个电负原子导致了抗炎活性的增加,表现为对4-羟基苯甲酸N-香草酰胺(13)的效力。结论:我们的数据可能可用于进一步设计用于口腔护理产品中强效抗炎添加剂的先导结构。
  • [EN] SWEETNESS AND TASTE IMPROVEMENT OF STEVIOL GLYCOSIDE AND MOGROSIDE SWEETENERS WITH DIHYDROCHALCONES<br/>[FR] AMÉLIORATION DE LA SUCROSITÉ ET DU GOÛT D'ÉDULCORANTS À BASE DE GLYCOSIDE DE STÉVIOL ET DE MOGROSIDE AVEC DES DIHYDROCHALCONES
    申请人:COCA COLA CO
    公开号:WO2018200663A1
    公开(公告)日:2018-11-01
    Compositions and consumables comprising certain sweeteners and at least one dihydrochalcone of Formula I are provided herein, wherein the at least one sweetener is selected from certain steviol glycoside and/or mogroside sweeteners in sweetening amounts. The at least one dihydrochalcone enhances the sweetness of the consumable and optionally modulates one or more taste attributes to make the consumable taste more like a sucrose-sweetened consumable. Methods of enhancing the sweetness of a consumable, methods of making a consumable taste more like a sucrose-sweetened consumable and methods of preparing consumables are also detailed herein.
    本文提供了包含某些甜味剂和至少一种式I的二氢黄酮的组合物和消耗品,其中至少一种甜味剂选自某些甜菊苷和/或蒙果甙甜味剂,用于调味。至少一种二氢黄酮增强了消耗品的甜味,并可选择性地调节一个或多个口味属性,使消耗品的口感更像蔗糖甜味的消耗品。本文还详细介绍了增强消耗品甜味的方法,使消耗品口感更像蔗糖甜味的方法以及制备消耗品的方法。
  • Diarylalkanes as potent inhibitors of binuclear enzymes
    申请人:Jia Qi
    公开号:US20050267047A1
    公开(公告)日:2005-12-01
    The present invention implements a strategy that combines an enzyme inhibition assay with a chemical dereplication process to identify active plant extracts and the particular compounds—diarylalkanes and/or diarylalkanols within those extracts that specifically inhibit binuclear enzyme function. Included in the present invention are compositions of matter comprised of one or more of diarylalkanes and/or diarylalkanols, which inhibit the activity of binuclear enzymes, particularly tyrosinase and which prevent melanin overproduction. The present invention also provides a method for inhibiting the activity of a binuclear enzyme, particularly tyrosinase and a method for preventing and treating diseases and conditions related to binuclear enzyme function. The present invention further includes a method for preventing and treating melanin overproduction and diseases and conditions of the skin related thereto. The method for preventing and treating diseases and conditions related to binuclear enzyme function and melanin overproduction is comprised of administering to a host in need thereof an effective amount of a composition comprising one or more diarylalkanes and/or diarylalkanols synthesized and/or isolated from one or more plants together with a pharmaceutically acceptable carrier.
    本发明实施了一种策略,将酶抑制测定与化学去重复过程相结合,以识别活性植物提取物和特定化合物——二芳基烷烃和/或二芳基醇,这些化合物特异性地抑制双核酶功能。本发明包括由一种或多种二芳基烷烃和/或二芳基醇组成的物质组合物,其抑制双核酶的活性,特别是酪氨酸酶,并防止黑色素过度产生。本发明还提供了一种抑制双核酶活性的方法,特别是酪氨酸酶,以及一种预防和治疗与双核酶功能相关的疾病和病况的方法。本发明还包括一种预防和治疗黑色素过度产生以及与之相关的皮肤疾病和病况的方法。预防和治疗与双核酶功能和黑色素过度产生相关的疾病和病况的方法包括向需要的宿主施用由一种或多种植物合成和/或分离的一种或多种二芳基烷烃和/或二芳基醇组成的组合物的有效量,以及药用载体。
  • Hemisynthesis and Biological Evaluation of Cinnamylated, Benzylated, and Prenylated Dihydrochalcones from a Common Bio-Sourced Precursor
    作者:Anne Ardaillou、Jérôme Alsarraf、Jean Legault、François Simard、André Pichette
    DOI:10.3390/antibiotics10060620
    日期:——

    Several families of naturally occurring C-alkylated dihydrochalcones display a broad range of biological activities, including antimicrobial and cytotoxic properties, depending on their alkylation sidechain. The catalytic Friedel–Crafts alkylation of the readily available aglycon moiety of neohesperidin dihydrochalcone was performed using cinnamyl, benzyl, and isoprenyl alcohols. This procedure provided a straightforward access to a series of derivatives that were structurally related to natural balsacones, uvaretin, and erioschalcones, respectively. The antibacterial and cytotoxic potential of these novel analogs was evaluated in vitro and highlighted some relations between the structure and the pharmacological properties of alkylated dihydrochalcones.

    几个天然存在的C-烷基化二氢黄酮家族展示了广泛的生物活性,包括抗菌和细胞毒性等性质,取决于它们的烷基化侧链。利用肉桂基、苄基和异戊二烯基醇对便利获得的新橙皮苷二氢黄酮的糖苷基进行傅-克反应烷基化反应。这个方法提供了一种简单的途径,制备了一系列结构与天然橙皮苷、紫梅素和二氢黄酮相关的衍生物。这些新型类似物的抗菌和细胞毒性潜力在体外得到评估,并突出了烷基化二氢黄酮的结构与药理特性之间的一些关系。
查看更多